Kinase Signaling in Apoptosis Induced by Saturated Fatty Acids in Pancreatic β-Cells

Jan Šrámek1, Vlasta Němcová-Fürstová2, Jan Kovář3

  • 1Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 11000, Czech Republic. jan.sramek@lf3.cuni.cz.

Insights

Saturated fatty acids induce pancreatic beta-cell death, a key factor in type 2 diabetes. This review explores how specific kinases, like JNK and PKC, may mediate this apoptosis, offering insights into diabetes mechanisms.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic beta-cell dysfunction is central to type 2 diabetes pathogenesis.
  • Chronic exposure to elevated fatty acids, particularly saturated ones, contributes to beta-cell failure.
  • The precise molecular pathways driving saturated fatty acid-induced beta-cell apoptosis remain incompletely understood.

Purpose of the Study:

  • To review the role of specific kinase signaling pathways in saturated fatty acid-induced apoptosis of pancreatic beta-cells.
  • To elucidate the molecular mechanisms underlying beta-cell death in the context of metabolic dysregulation.

Main Methods:

  • Literature review focusing on kinase signaling pathways.
  • Analysis of studies investigating saturated fatty acid effects on beta-cells.
  • Discussion of proposed mechanisms involving JNK, PKC, p38 MAPK, ERK, and Akt pathways.

Main Results:

  • Kinase signaling pathways, including c-Jun N-terminal kinase (JNK), protein kinase C (PKC), p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK), and Akt, are implicated in beta-cell apoptosis.
  • These kinases and their associated signaling cascades represent potential mediators of saturated fatty acid-induced beta-cell death.

Conclusions:

  • Kinase signaling pathways are critically involved in the process of apoptosis induced by saturated fatty acids in pancreatic beta-cells.
  • Understanding these pathways is crucial for developing therapeutic strategies targeting type 2 diabetes by protecting beta-cell function.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K